# Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy

> **NCT02300727** · PHASE1,PHASE2 · TERMINATED · sponsor: **Amy Beres** · enrollment: 6 (actual)

## Conditions studied

- Mucositis

## Interventions

- **DRUG:** Curcumin-MTD
- **DRUG:** Mouthwash-standard pharmacy preparation
- **DRUG:** Curcumin

## Key facts

- **NCT ID:** NCT02300727
- **Lead sponsor:** Amy Beres
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02
- **Primary completion:** 2018-10-25
- **Final completion:** 2018-10-25
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Protocol failed to accrue sufficient subject to complete meaningful analysis.
- **Last updated:** 2019-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02300727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02300727, "Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02300727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*